Cargando…
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
BACKGROUND: Pharmaceutical companies in Africa need to invest in both facilities and quality management systems to achieve good manufacturing practice (GMP) compliance. Compliance to international GMP standards is important to the attainment of World Health Organization (WHO) prequalification. Howev...
Autores principales: | Anyakora, Chimezie, Ekwunife, Obinna, Alozie, Faith, Esuga, Mopa, Ukwuru, Jonathan, Onya, Steve, Nwokike, Jude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604295/ https://www.ncbi.nlm.nih.gov/pubmed/28923044 http://dx.doi.org/10.1186/s12913-017-2610-8 |
Ejemplares similares
-
Continuous Pharmaceutical Manufacturing
por: Korhonen, Ossi
Publicado: (2020) -
A descriptive study of healthcare-providers’ experiences with the use and quality of oxytocin for the prevention of post-partum hemorrhage in Nigeria: A nation-wide survey
por: Ejekam, Chioma S., et al.
Publicado: (2021) -
A Comparative Investment Analysis of Batch Versus Continuous Pharmaceutical Manufacturing Technologies
por: Rossi, Clifford V.
Publicado: (2022) -
Pharmaceutical manufacturing change control /
Publicado: (1999) -
The Future of Pharmaceutical Manufacturing Sciences
por: Rantanen, Jukka, et al.
Publicado: (2015)